Soleus Private Equity Fund III, L.P. 13D and 13G filings for Immunic, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:00 pm Sale | 2025-09-30 | 13G | IMMUNIC INC IMUX | Soleus Private Equity Fund III, L.P. | 1,580,007 1.600% | -5,713,000 (-78.34%) | Filing |
| 2024-01-10 09:00 am Purchase | 2024-01-08 | 13G | IMMUNIC INC IMUX | Soleus Private Equity Fund III, L.P. | 7,293,007 8.100% | 7,293,007 (New Position) | Filing |